Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 /2 Multicenter, Basket, Imaging Study Investigating the Safety and Diagnostic Performance of RYZ711 in Men With Prostate Cancer.

NCT07862582 is registered in ClinicalTrials.gov with RayzeBio, Inc. as lead sponsor.

NCT NCT07862582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07862582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 /2 Multicenter, Basket, Imaging Study Investigating the Safety and Diagnostic Performance of RYZ711 in Men With Prostate Cancer.
Lead sponsor
RayzeBio, Inc.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2027
Enrollment
116 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, biochemical recurrence (bcr), high-risk localized prostate cancer, metastatic castration-resistant prostate cancer (mcrpc), metastatic hormone-sensitive prostate cancer (mhspc), prostate cancer (adenocarcinoma)